S.H. Lowe

Vasylyev, M., Wit, F. W. N. M., Jordans, C. C. E., Soetekouw, R., van Lelyveld, S. F. L., Kootstra, G. J., Delsing, C. E., Ammerlaan, H. S. M., van Kasteren, M. E. E., Brouwer, A. E., Leyten, E. M. S., Claassen, M. A. A., Hassing, R. J., den Hollander, J. G., van den Berge, M., Roukens, A. H. E., Bierman, W. F. W., Groeneveld, P. H. P., Lowe, S. H., ... AIDS Therapy Evaluation in the Netherlands (ATHENA) Observational HIV Cohort (2024). Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study. Open Forum Infectious Diseases, 11(4), Article ofae160. https://doi.org/10.1093/ofid/ofae160

Hensley, K. S., Jongkees, M. J., Geers, D., GeurtsvanKessel, C. H., Mueller, Y. M., Dalm, V. A. S. H., Papageorgiou, G., Steggink, H., Gorska, A., Bogers, S., den Hollander, J. G., Bierman, W. F. W., Gelinck, L. B. S., Schippers, E. F., Ammerlaan, H. S. M., van der Valk, M., van Vonderen, M. G. A., Delsing, C. E., Gisolf, E. H., ... Rokx, C. (2022). Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study. PLOS Medicine , 19(10), Article e1003979. https://doi.org/10.1371/journal.pmed.1003979

Vourli, G., Noori, T., Pharris, A., Porter, K., Axelsson, M., Begovac, J., Cazein, F., Costagliola, D., Cowan, S., Croxford, S., Monforte, A. D. A., Delpech, V., Díaz, A., Girardi, E., Gunsenheimer-Bartmeyer, B., Hernando, V., Leierer, G., Lot, F., Nunez, O., ... Havenith, T. (2020). Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? Clinical Infectious Diseases, 71(11), 2905-2916. https://doi.org/10.1093/cid/ciaa696

Wijting, I. E. A., Wit, F. W. N. M., Rokx, C., Leyten, E. M. S., Lowe, S. H., Brinkman, K., Bierman, W. F. W., van Kasteren, M. E. E., Postma, A. M., Bloemen, V. C. M., Bouchtoubi, G., Hoepelman, A. I. M., van der Ende, M. E., Reiss, P., Rijnders, B. J. A., & ATHENA National Observational HIV Cohort (2019). Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy. EClinicalMedicine, 17, Article 100210. https://doi.org/10.1016/j.eclinm.2019.11.003

van Zoest, R. A., Law, M., Sabin, C. A., Vaartjes, I., Van der Valk, M., Arends, J. E., Reiss, P., Wit, F. W., Geerlings, S. E., Godfried, M. H., Goorhuis, A., Hovius, J. W., Kuijpers, T. W., Nellen, F. J. B., van der Poll, D. T., Prins, J. M., van Vugt, H. J. M., Wiersinga, W. J., Wit, F. W. M. N., ... ATHENA National Observational HIV Cohort (2019). Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV. JAIDS: journal of Acquired Immune Deficiency Syndromes, 81(5), 562-571. https://doi.org/10.1097/QAI.0000000000002069

Newsum, A. M., Kooij, K. W., Boyd, A., Smit, C., Wit, F. W. N. M., van der Meer, J. T. M., Prins, M., Reiss, P., van der Valk, M., van Eden, H., Molenkamp, R., Pijnappel, F., Reesink, H. W., Schinkel, J., Steba, G. S., van den Berk, G. E. L., Brinkman, K., Hooijenga, Kwa, D., ... ATHENA Observational HIV Cohort (2019). Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM. Aids, 33(5), 833-844. https://doi.org/10.1097/QAD.0000000000002138

Peltenburg, N. C., Bierau, J., Schippers, J. A., Lowe, S. H., Paulussen, A. D. C., van den Bosch, B. J. C., Leers, M. P. G., Andrinopoulou, E.-R., Bakker, J. A., & Verbon, A. (2019). Metabolic events in HIV-infected patients using abacavir are associated with erythrocyte inosine triphosphatase activity. Journal of Antimicrobial Chemotherapy, 74(1), 157-164. https://doi.org/10.1093/jac/dky383

Peltenburg, N. C., Schoeman, J. C., Hou, J., Mora, F., Harms, A. C., Lowe, S. H., Bierau, J., Bakker, J. A., Verbon, A., Hankemeier, T., & Boonstra, A. (2018). Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy. Scientific Reports, 8(1), Article 16947. https://doi.org/10.1038/s41598-018-35271-0

Peltenburg, N. C., Bierau, J., Bakker, J. A., Schippers, J. A., Lowe, S. H., Paulussen, A. D. C., van den Bosch, B. J. C., Leers, M. P. G., Hansen, B. E., & Verbon, A. (2018). Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV. PLOS ONE, 13(1), Article e0191069. https://doi.org/10.1371/journal.pone.0191069

Peltenburg, N. C., Leers, M. P. G., Bakker, J. A., Lowe, S. H., Vroemen, W. H. M., Paulussen, A. D. C., van den Bosch, B. J. C., Bierau, J., & Verbon, A. (2016). Inosine Triphosphate Pyrophosphohydrolase Expression: Decreased in Leukocytes of HIV-Infected Patients Using Combination Antiretroviral Therapy. JAIDS: journal of Acquired Immune Deficiency Syndromes, 73(4), 390-395. https://doi.org/10.1097/QAI.0000000000001130